Method for manufacturing patient-specific human platelets

Skin cells from humans can be revamped into pro-clotting cells called platelets, according to a study published on November 22 in the Journal of Experimental Medicine. Patients with diseases causing thrombocytopenia—platelet deficiency—often require repeated transfusions with platelets obtained from healthy donors.

Read the whole article on Physorg

More from Physorg